Valuation: Becton, Dickinson and Company

Market Cap 42.96B 37.67B 34.72B 32.51B 60.96B 4,053B 62.22B 417B 161B 2,003B 161B 158B 6,945B P/E 2026 *
38.9x
P/E 2027 * 30x
Enterprise Value 58.92B 51.66B 47.62B 44.58B 83.59B 5,558B 85.33B 572B 221B 2,747B 221B 216B 9,525B EV / Sales 2026 *
3.07x
EV / Sales 2027 * 2.89x
Free-Float
74.04%
Yield 2026 *
2.47%
Yield 2027 * 2.51%
1 day+3.00%
1 week+8.29%
Current month+5.98%
1 month+5.06%
3 months+0.91%
6 months-20.58%
Current year-19.66%
1 week 141.25
Extreme 141.25
156.89
1 month 140.11
Extreme 140.11
156.89
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
287.32
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 27/01/2020
Director of Finance/CFO 44 04/12/2025
Compliance Officer - 31/01/2023
Director TitleAgeSince
Director/Board Member 75 23/09/2002
Director/Board Member 71 25/07/2010
Chairman 53 27/04/2021
Date Insider Type Main position Quantity % Market Cap.
06-25Sell

Executive/Senior Manager

-75 0.0000%
06-23Sell

Executive/Senior Manager

-1,100 0.0004%
06-21Other

EVP and Chief People Officer

39,984 0.0145%
Change 5-day change 1-year change 3-year change Capi.($)
+3.00%+8.29%-8.74%-39.80% 42.96B
+0.94%+6.46%-29.96%-12.54% 164B
+0.57%+2.07%-5.86%-6.23% 104B
-0.29%+5.26%-4.44%+50.82% 55.67B
+0.90%-4.34%+50.42%+52.78% 52.92B
+2.91%+8.15% - - 32.87B
+2.17%-3.22%-18.75%-44.52% 27.07B
+1.24%+6.98%+60.30%-4.97% 24.79B
+2.41%+6.45%-9.68%-0.56% 21.02B
+1.58%+0.11%-15.21%-2.96% 20.18B
Average +1.32%+3.38%+2.01%-0.89% 54.51B
Weighted average by Cap. +0.97%+3.81%-5.85%-0.37%

Financials

2026 *2027 *
Net sales 19.21B 16.84B 15.52B 14.53B 27.25B 1,812B 27.81B 187B 72.19B 895B 72.12B 70.54B 3,105B 19.71B 17.28B 15.93B 14.91B 27.97B 1,859B 28.55B 191B 74.09B 919B 74.01B 72.4B 3,186B
Net income 1.12B 986M 909M 851M 1.6B 106B 1.63B 10.92B 4.23B 52.43B 4.22B 4.13B 182B 1.45B 1.27B 1.17B 1.1B 2.06B 137B 2.1B 14.08B 5.45B 67.56B 5.44B 5.32B 234B
Net Debt 15.95B 13.99B 12.89B 12.07B 22.64B 1,505B 23.11B 155B 59.97B 744B 59.91B 58.6B 2,579B 14.07B 12.34B 11.37B 10.65B 19.97B 1,327B 20.38B 137B 52.9B 656B 52.84B 51.69B 2,275B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
26/06/26 US$155.92 +3.00% 12,180,748
25/06/26 US$151.38 +2.44% 2,548,949
24/06/26 US$147.77 +2.68% 2,300,230
23/06/26 US$143.92 +2.28% 2,908,134
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
155.92USD
Average target price
177.75USD
Spread / Average Target
+14.00%

Quarterly revenue - Rate of surprise